MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Visualizzazioni
• 07/02/23
0
0
Incorporare
administrator
Iscritti
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti